G1 Therapeutics Inc (GTHX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 09-2016 | 06-2016 | 12-2015 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -30,290 | -19,890 | -13,333 | -20,260 |
| Depreciation Amortization | 60 | 44 | 26 | 40 |
| Other Working Capital | 3,590 | 2,970 | 2,097 | 940 |
| Other Operating Activity | 1,500 | 945 | 564 | 5,440 |
| Operating Cash Flow | $-25,140 | $-15,931 | $-10,646 | $-13,840 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -250 | -209 | -85 | -80 |
| Investing Cash Flow | $-250 | $-209 | $-85 | $-80 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | N/A | 5 | 5 | N/A |
| Other Financing Activity | 49,750 | 49,751 | 49,751 | 33,170 |
| Financing Cash Flow | $49,750 | $49,756 | $49,756 | $33,170 |
| Beginning Cash Position | 22,930 | 22,938 | 22,938 | 3,690 |
| End Cash Position | 47,300 | 56,554 | 61,963 | 22,930 |
| Net Cash Flow | $24,360 | $33,616 | $39,025 | $19,240 |
| Free Cash Flow | ||||
| Operating Cash Flow | -25,140 | -15,931 | -10,646 | -13,840 |
| Capital Expenditure | N/A | -209 | -85 | N/A |
| Free Cash Flow | -25,140 | -16,140 | -10,731 | -13,840 |